Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.

Trezise S, Karnowski A, Fedele PL, Mithraprabhu S, Liao Y, D'Costa K, Kueh AJ, Hardy MP, Owczarek CM, Herold MJ, Spencer A, Shi W, Willis SN, Nutt SL, Corcoran LM.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2161. doi: 10.3390/ijms19082161.

2.

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.

Mithraprabhu S, Sirdesai S, Chen M, Khong T, Spencer A.

Int J Mol Sci. 2018 Jun 24;19(7). pii: E1858. doi: 10.3390/ijms19071858.

3.

Analysis of Circulating Tumor DNA.

Mithraprabhu S, Spencer A.

Methods Mol Biol. 2018;1792:129-145. doi: 10.1007/978-1-4939-7865-6_9.

PMID:
29797256
4.

Circulating tumour DNA analysis in multiple myeloma.

Mithraprabhu S, Spencer A.

Oncotarget. 2017 Oct 7;8(53):90610-90611. doi: 10.18632/oncotarget.21595. eCollection 2017 Oct 31. No abstract available.

5.

Heavy menstrual bleeding and dysmenorrhea are improved by Magnetic Resonance Guided Focused Ultrasound Surgery (MRgFUS) of adenomyosis.

Jayaram R, Subbarayan K, Mithraprabhu S, Govindarajan M.

Fertil Res Pract. 2016 May 16;2:8. doi: 10.1186/s40738-016-0021-x. eCollection 2016.

6.

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Hocking J, Mithraprabhu S, Kalff A, Spencer A.

Cancer Biol Med. 2016 Jun;13(2):215-25. doi: 10.20892/j.issn.2095-3941.2016.0025.

7.

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Mithraprabhu S, Kalff A, Chow A, Khong T, Spencer A.

Epigenetics. 2014 Nov;9(11):1511-20. doi: 10.4161/15592294.2014.983367.

8.

A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.

Kalff A, Khong T, Wall M, Gorniak M, Mithraprabhu S, Campbell LJ, Spencer A.

Haematologica. 2015 Feb;100(2):e60-2. doi: 10.3324/haematol.2014.111385. Epub 2014 Nov 7. No abstract available.

9.

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.

Mithraprabhu S, Khong T, Jones SS, Spencer A.

Br J Haematol. 2013 Aug;162(4):559-62. doi: 10.1111/bjh.12388. Epub 2013 May 21. No abstract available.

PMID:
23692150
10.

Deactylase inhibition in myeloproliferative neoplasms.

Mithraprabhu S, Grigoriadis G, Khong T, Spencer A.

Invest New Drugs. 2010 Dec;28 Suppl 1:S50-7. doi: 10.1007/s10637-010-9590-4. Epub 2010 Dec 3. Review.

11.

Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo.

Mithraprabhu S, Mendis S, Meachem SJ, Tubino L, Matzuk MM, Brown CW, Loveland KL.

Biol Reprod. 2010 May;82(5):980-90. doi: 10.1095/biolreprod.109.079855. Epub 2010 Feb 3.

12.

Control of KIT signalling in male germ cells: what can we learn from other systems?

Mithraprabhu S, Loveland KL.

Reproduction. 2009 Nov;138(5):743-57. doi: 10.1530/REP-08-0537. Epub 2009 Jun 30. Review.

PMID:
19567460

Supplemental Content

Loading ...
Support Center